MedImmune Considers Sale
Filed in archive Corporate and Industrial News by ruth on April 13, 2007

FluMist, is considering acquisition offers from third parties. It has hired Goldman Sachs & Co. and the law firm Dewey Ballantine to help with a possible sale.
[snip].. indications of interest by major pharmaceutical companies, coupled with recent expressions by certain stockholders of dissatisfaction with the company's short-term stock price performance, have led the board to authorize management to gather information regarding possible strategic interest in acquiring the company.
More backgrounder info from Chron.com.
Permalink: MedImmune Considers Sale
Tags:
MedImmune investment pharma pharmaceutical vaccine FluMist biotech considers+sale
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/63348







